The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIQE Regulatory News (IQE)

Share Price Information for IQE (IQE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 34.00
Bid: 33.90
Ask: 34.25
Change: 0.25 (0.74%)
Spread: 0.35 (1.032%)
Open: 33.80
High: 34.15
Low: 33.10
Prev. Close: 33.75
IQE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

IQE Announces Full Product Qualification and First Mass Production Order for Newport Mega Foundry for Epi Materials

2 May 2019 07:00



IQE Announces Full Product Qualification and First Mass Production Order for Newport Mega Foundry for Epi Materials

Cardiff, UK, 2 May 2019. IQE (AIM:IQE) announces that its recently constructed Newport Mega Foundry has received its first mass production order from its leading existing VCSEL customer.

The achievement of full product qualification status is the result of extensive quality and process audits by the customer and their end OEM, as well as exhaustive product qualification trials including full reliability testing. Qualification of further tools is in progress and is expected to complete over the coming months.

In addition to the qualification with this customer, further VCSEL product qualifications are at advanced stages with more than ten other customers, two of which are expected to reach a successful conclusion over the next few weeks.

Customer feedback from the additional qualifications confirms the superior quality and performance from the new facility.

The Newport Mega Foundry is the largest outsource epi facility for advanced compound semiconductors globally and has been under construction for the last 18 months. It currently has ten large-scale production MOCVD tools installed, with space for up to an additional 90 tools. The manufacturing facility also houses an extensive suite of highly advanced wafer characterization tools to ensure outstanding, world-class wafer quality.

The first ten tools are dedicated to 6” VCSEL production for end applications that include 3D sensing, high-speed datacoms, Advanced Driver Assistance Systems (ADAS), LiDAR, proximity sensing and Time of Flight (ToF) systems.

IQE is the global leader in the production of VCSEL wafers, with unique, extensive experience of mass production for consumer applications and a proven track record of ultra-high reliability product deployment. The market for VCSELs is expected to grow rapidly over the coming years as 3D sensing is installed across multiple user platforms, including facial recognition, world facing cameras for Augmented Reality (AR) and 3D photography, security cameras, industrial sensing and heating, ADAS, LiDAR, high speed datacomms and proximity sensing.

In addition to its leadership in the sector, IQE is also developing integrated solutions using advanced wafer processing technologies such as Nanoimprint Lithography (NIL) and Quasi Photonic Crystals (QPC) to enhance the functionality and performance of VCSEL arrays.

This order and the commencement of production is in line with our previously provided revenue guidance for 2019.

 Dr Drew Nelson, CEO and President of IQE commented:

“I am very pleased to announce IQE’s receipt of full product qualification status from our leading VCSEL customer, and the first order for mass production from our new Mega Epi foundry in Newport.

“IQE has invested heavily, along with help from the Cardiff City Region Deal (CCR), to build the worlds largest outsource epi facility, demonstrating our commitment to providing the capacity required for large scale deployment of VCSELs and other Compound Semiconductor (CS) products, as the CS industry moves through a real inflection point in volume manufacture.

“IQE is committed to leadership of this mass CS scaling, offering a unique range of wafer products and complementary technologies, enabling our customers to introduce disruptive products to the end marketplace. We have a powerful and extensive roadmap for VCSEL technology, which we believe will help the acceleration of the deployment of VCSELs across many end applications”

CONTACTS

IQE plc +44 (0) 29 2083 9400Drew Nelson Tim PullenChris Meadows

Canaccord Genuity (Nomad and Joint Broker)+ 44 (0) 20 7523 8000 Simon Bridges Richard Andrews

Peel Hunt (Joint Broker)+44 (0) 20 7418 8900Edward KnightNick Prowting


Date   Source Headline
22nd Aug 20137:00 amRNSIQE reports new CPV cell efficiency
5th Jun 20132:22 pmRNSMerger Update
8th Mar 20133:00 pmRNSMerger Update
8th Jan 20138:39 amRNSStatement regarding press articles
31st Jul 20123:54 pmRNSDirectorate Change
10th Apr 20125:11 pmRNSDirector Dealings
27th Mar 20122:00 pmRNSPartnership Agreement
8th Feb 20124:10 pmRNSCompletion of Placing
17th Feb 20103:56 pmRNSNominated Adviser Change of Name
7th Aug 20094:42 pmRNSHolding(s) in Company
7th Aug 20094:30 pmRNSBondholders meeting
7th Aug 20093:51 pmRNSDirector Dealing in Shares
12th Jun 20081:42 pmRNSAdditional Listing
15th Apr 20087:01 amRNSAdditional Listing
7th Apr 200812:14 pmRNSDirector/PDMR Shareholding
28th Mar 200811:52 amRNSDirector/PDMR Shareholding
19th Mar 20087:00 amRNSDirector/PDMR Shareholding
17th Mar 20081:00 pmRNSContract Win
17th Mar 20087:01 amRNSFinal Results
28th Feb 20083:27 pmRNSHolding(s) in Company
19th Feb 20088:30 amRNSNotice of Results
25th Jan 20087:00 amRNSBank Facilities
17th Jan 20087:00 amRNSTrading Update
16th Jan 200811:15 amRNSBroker Appointment
15th Jan 200812:12 pmRNSDirector/PDMR Shareholding
9th Jan 20084:26 pmRNSAdditional Listing
7th Jan 20087:00 amRNSDirector/PDMR Shareholding
4th Jan 200812:46 pmRNSHolding(s) in Company
19th Dec 20077:30 amRNSAdditional Listing
18th Dec 20073:52 pmRNSSubstrate supply contract
13th Dec 20077:01 amRNSSuccessful Qualifications
9th Nov 200710:53 amRNSDirector/PDMR Shareholding
3rd Oct 200710:41 amRNSDirector/PDMR Shareholding
1st Oct 20072:44 pmRNSAdditional Listing
28th Sep 200710:14 amRNSContract Win
28th Sep 20078:12 amRNSInvestor Presentation
4th Sep 200712:03 pmRNSDirector/PDMR Shareholding
28th Aug 20072:17 pmRNSHolding(s) in Company
24th Aug 20073:36 pmRNSHolding(s) in Company
22nd Aug 20077:01 amRNSContract Win
22nd Aug 20077:01 amRNSInterim Results
15th Aug 20077:01 amRNSIFRS Transitional Stmnt - Amd
14th Aug 20077:01 amRNSIFRS Transitional Statement
13th Aug 20071:19 pmRNSRule 26 Compliance
2nd Aug 20078:39 amRNSResearch Consortium
1st Aug 20073:52 pmRNSNotice of Results
25th Jul 20071:35 pmRNSResult of AGM
11th Jul 20078:00 amRNSHolding(s) in Company
9th Jul 20077:00 amRNSTrading Statement
18th Jun 20073:35 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.